** Shares of Algorae Pharmaceuticals 1AI.AX rise as much 14.35 to A$0.008, their highest levels since Nov 21
** The pharma co says it received positive outcomes from pre-clinical studies for drug candidate AI-168
** Says drug demonstrates "statistically significant" cardio-protective qualities
** Stock on track for second straight session of gains
** Over 9.6 mln shares change hands, compared with the 30-day average volume of 1.4 mln
** 1AI stock down 20% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。